Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Pratley

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Current Diabetes Reports|June 30, 2017
Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next StepsKimberly A Driscoll, Karen D Corbin, David M Maahs, et al.
Diabetes, Obesity & Metabolism|October 7, 2020
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonistHertzel C Gerstein, Kelley Branch, Laura Heenan, et al.
Diabetes Research and Clinical Practice|December 12, 2022
"Nothing is linear": Characterizing the determinants and dynamics of CGM use in older adults with type 1 diabetesAnna R Kahkoska, Cambray Smith, Sirisha Thambuluru, et al.
Journal of Diabetes and Its Complications|April 2, 2024
Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) studyLuciana Mascarenhas Fonseca, Lauren Kanapka, Kellee Miller, et al.
Diabetes Research and Clinical Practice|June 21, 2023
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) studyDaniel S Hsia, Jason Nelson, Ellen M Vickery, et al.
Diabetes Care|February 8, 2020
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D ExchangeKara R Mizokami-Stout, Zoey Li, Nicole C Foster, et al.
Diabetes, Obesity & Metabolism|December 20, 2023
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trialHertzel C Gerstein, Rajibul Mian, Chinthanie Ramasundarahettige, et al.
Diabetes, Obesity & Metabolism|July 24, 2020
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studiesRichard Pratley, Samuel Dagogo-Jack, Bernard Charbonnel, et al.
Lancet (London, England)|June 6, 2003
Effect of a diabetic environment in utero on predisposition to type 2 diabetesEugène Sobngwi, Philippe Boudou, Franck Mauvais-Jarvis, et al.
Pediatric Diabetes|September 27, 2020
Dietary intake on days with and without hypoglycemia in youth with type 1 diabetes: The Flexible Lifestyle Empowering Change trialDaria Igudesman, Jamie Crandell, Victor W Zhong, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Current Diabetes Reports|June 30, 2017
Biopsychosocial Aspects of Weight Management in Type 1 Diabetes: a Review and Next StepsKimberly A Driscoll, Karen D Corbin, David M Maahs, et al.
Diabetes, Obesity & Metabolism|October 7, 2020
Design and baseline characteristics of the AMPLITUDE-O cardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonistHertzel C Gerstein, Kelley Branch, Laura Heenan, et al.
Diabetes Research and Clinical Practice|December 12, 2022
"Nothing is linear": Characterizing the determinants and dynamics of CGM use in older adults with type 1 diabetesAnna R Kahkoska, Cambray Smith, Sirisha Thambuluru, et al.
Journal of Diabetes and Its Complications|April 2, 2024
Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) studyLuciana Mascarenhas Fonseca, Lauren Kanapka, Kellee Miller, et al.
Diabetes Research and Clinical Practice|June 21, 2023
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) studyDaniel S Hsia, Jason Nelson, Ellen M Vickery, et al.
Diabetes Care|February 8, 2020
The Contemporary Prevalence of Diabetic Neuropathy in Type 1 Diabetes: Findings From the T1D ExchangeKara R Mizokami-Stout, Zoey Li, Nicole C Foster, et al.
Diabetes, Obesity & Metabolism|December 20, 2023
Cardiovascular and renal outcomes with varying degrees of kidney disease in high-risk people with type 2 diabetes: An epidemiological analysis of data from the AMPLITUDE-O trialHertzel C Gerstein, Rajibul Mian, Chinthanie Ramasundarahettige, et al.
Diabetes, Obesity & Metabolism|July 24, 2020
Efficacy and safety of ertugliflozin in older patients with type 2 diabetes: A pooled analysis of phase III studiesRichard Pratley, Samuel Dagogo-Jack, Bernard Charbonnel, et al.
Lancet (London, England)|June 6, 2003
Effect of a diabetic environment in utero on predisposition to type 2 diabetesEugène Sobngwi, Philippe Boudou, Franck Mauvais-Jarvis, et al.
Pediatric Diabetes|September 27, 2020
Dietary intake on days with and without hypoglycemia in youth with type 1 diabetes: The Flexible Lifestyle Empowering Change trialDaria Igudesman, Jamie Crandell, Victor W Zhong, et al.
Pageof 7